BOSTON-BASED VALO HEALTH, WHICH ANALYZES CLINICAL DATA TO IDENTIFY MOLECULES AND PREDICT THEIR CHANCES FOR USE IN DRUGS, RAISES $300M SERIES B (DANIEL MCCOY/WICHITA BUSINESS JOURNAL)
Daniel McCoy / Wichita Business Journal: Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for...